Key Quantitative Figures

  • IPO Size: Public issue of 27,90,000 equity shares
  • Amount Raised: ₹37,66,50,000 (37.665 crore)
  • Date of Fund Raising: 30th May, 2025
  • Total Utilized Amount as of 31-Mar-2026: ₹35,91,15,998 (35.911 crore)
  • Unutilized Amount as of 31-Mar-2026: ₹1,75,34,002 (1.753 crore)
  • Strategic Investment Amount: ₹6,25,00,000 (6.25 crore) allocated for acquisition of equity shares in Damaira Pharmaceuticals Private Limited

Approval Timeline

  • Board Approval Date: 27th February, 2026
  • Shareholder Approval Date: 27th March, 2026 (Extra-Ordinary General Meeting)
  • Implementation Date: The entire approved deviation amount was utilized towards acquisition of equity stake in Damaira Pharmaceuticals Private Limited on 30th March, 2026

Revised Fund Allocation and Utilization (as of 31-Mar-2026)

The company provided a detailed breakdown of the original allocation, revised allocation, and utilization:

| Object | Original Allocation (₹) | Revised Allocation (₹) | Utilized Amount (₹) |

| Registration in Bolivia, South America | 1,28,97,000 | 75,00,000 | 8,34,230 |

| Plant and machineries for ointment production | 5,23,40,000 | 3,00,57,814 | 3,00,57,814 |

| Advertising, marketing and brand building | 4,95,15,000 | 2,00,15,000 | 2,00,15,000 |

| Hardware and software procurement | 68,38,000 | 15,44,825 | 15,44,825 |

| Working capital requirements | 19,75,00,000 | 19,75,00,000 | 19,75,00,000 |

| General corporate purposes | 1,98,81,000 | 1,98,53,361 | 89,85,129 |

| Issue Expense | 3,76,79,000 | 3,76,79,000 | 3,76,79,000 |

| Investment in Damaira Pharmaceuticals | - | 6,25,00,000 | 6,25,00,000 |

| Total | 37,66,50,000 | 37,66,50,000 | 35,91,15,998 |

Rationale for Deviation

The company stated the reallocation reflects "prudent capital re-prioritization to leverage growth opportunities and strengthen long-term business synergies, without affecting the Company's core operational objectives, which remain fully funded."

Additional Corporate Information

  • GSTIN: 06AAPCA4446E1ZP
  • Former Name: Astonea Labs Private Limited
  • Corporate Office: 63, Industrial Area, Phase II, Panchkula, Haryana, India-134113
  • Plant: Village Haripur, Teh. Raipur Rani, Distt., Panchkula, India-134204